As Baker McKenzie continues to expand its transactional capabilities in New York, the Firm added highly regarded corporate practitioner Jan Joosten as a Partner in its North American Corporate & Securities Practice. Mr. Joosten brings more than 20 years of experience advising clients on mergers and acquisitions, joint ventures and capital markets transactions.
"Jan is the latest in a series of prominent transactional attorneys we added to our team in New York," said Amar Budarapu, Chair of Baker McKenzie's North American Corporate & Securities Practice. "He has built a reputation as a 'go-to' advisor on cross-border transactions, and he will bring valuable insights to our clients seeking guidance on their global transactions. We are very pleased to have him join our team."
Mr. Joosten also has extensive experience representing Dutch and other European companies doing business in the US in a broad range of matters. He joins the Firm from Hughes Hubbard & Reed LLP.
"Jan brings a track record of success advising clients on a range of global M&A related matters," said Jim Colihan, Managing Partner of Baker McKenzie's New York office. "His expertise handling complex transactions will be an immediate asset to our team, and more importantly, our clients."
Throughout his career, Mr. Joosten has handled a range of complex cross-border work. Some of his recent representative matters include:
- Representation of T-Cell Factory B.V., a Dutch biotechnology company, in its sale to Kite Pharma Inc. Through this acquisition, Kite Pharma gained access to T-Cell Factory's TCR-GENErator technology platform, which rapidly and systematically discovers, characterizes and selects tumor-specific T-cell receptors of therapeutic value.
- Representation of ITT Corporation in acquisitions of: Wolverine Automotive Holdings Inc., the parent company of Wolverine Advanced Materials LLC, a global market leader in technologies for automotive braking systems and sealing solutions across a range of industries; and Hartzell Aerospace LLC, a leading manufacturer of highly engineered and customized solutions for aerospace environmental control systems.
- Representation of Clinquest Group B.V., a contract research company, in connection with its sale of Clinquest, Inc. (US) and Clinquest Services B.V. (the Netherlands) to Accelovance, Inc., a U.S.-based clinical research organization.
Jan is a top flight transactional attorney whose experience representing a range of multinationals around the world is truly impressive,
said Michael DeFranco, Chair of the Firm's Global M&A Practice.
Added Rick Hammett, Baker McKenzie's North American Managing Partner, "We are committed to further enhancing our services throughout North America with the addition of strong lateral talent. Jan is another great hire that expands our transactional capabilities in a key market for our clients and for our firm."
In addition to his transactional work, Mr. Joosten lectures extensively on topics such as cross-border M&A and US securities law. He has been recognized by Chambers Global as a regional expert in corporate M&A.
"Baker McKenzie's long history and impressive track record as the leading cross-border firm makes it an excellent fit for my practice," Mr. Joosten said. "I am excited to join Baker McKenzie's growing transactional team in New York."
Originally from the Netherlands, Mr. Joosten received a Master of Civil Law and a Master of Tax Law from Leiden University as well as an LL.M. from Harvard Law School. Mr. Joosten is fluent in English and Dutch, and has a working knowledge of French and German.
A Recognized and Growing Transactional Practice
Baker McKenzie is one of the world's most active transactional law firms, handling more cross-border deals than any other law firm in the world. Thomson Reuters has ranked Baker McKenzie No. 1 for announced and completed cross-border M&A deals by volume for the past three years, and for the first half of 2016, Dealogic ranked the Firm No. 5 worldwide in volume of global M&A deals it has handled.
The Firm has accelerated the growth of its transactional practice in New York in recent months. For example, the Firm recently added corporate practitioners Steven Canner and Nick Marchica, restructuring and insolvency attorneys Debra Dandeneau and Peter Goodman, and Mark Tibberts, a leading project finance attorney. The Firm has also added expertise in New York in other areas including tax, finance and litigation, with 15 lateral partners joining over the last two years in that market. Overall, Baker McKenzie has added 42 lateral partners in North America over the last two years, as it continues to strengthen its presence in key markets.
The practice has advised on a string of recent global transactions, including Baxter's spinoff of its biopharmaceutical division; Meiji Yasuda Life Insurance Company's acquisition of StanCorp Financial Group, Inc., one of the largest acquisitions of an overseas corporation by a Japanese insurance company in history; and Cardtronic Inc's redomicile from Delaware to the United Kingdom.